Research ArticleBIOPHYSICS

A highly conserved 310 helix within the kinesin motor domain is critical for kinesin function and human health

See allHide authors and affiliations

Science Advances  30 Apr 2021:
Vol. 7, no. 18, eabf1002
DOI: 10.1126/sciadv.abf1002


KIF1A is a critical cargo transport motor within neurons. More than 100 known mutations result in KIF1A-associated neurological disorder (KAND), a degenerative condition for which there is no cure. A missense mutation, P305L, was identified in children diagnosed with KAND, but the molecular basis for the disease is unknown. We find that this conserved residue is part of an unusual 310 helix immediately adjacent to the family-specific K-loop, which facilitates a high microtubule-association rate. We find that the mutation negatively affects several biophysical parameters of the motor. However, the microtubule-association rate of the motor is most markedly affected, revealing that the presence of an intact K-loop is not sufficient for its function. We hypothesize that the 310 helix facilitates a specific K-loop conformation that is critical for its function. We find that the function of this proline is conserved in kinesin-1, revealing a fundamental principle of the kinesin motor mechanism.


Kinesins are molecular motor proteins that hydrolyze adenosine triphosphate (ATP) to move processively along, or actively remodel, microtubules (MTs) within cells. The kinesin superfamily [KIF; (1)] in humans is large, containing ~45 genes with diverse functions. KIF1A is a member of the large kinesin-3 (KIF1) subfamily known to participate in long-distance transport of various cellular cargos, primarily within neurons (2). KIF1A has unique biophysical properties, being among the fastest and most processive kinesins reported to date (25). The kinesin motor core is highly conserved among different families, with distinct insertions in loop regions often accounting for specific biophysical adaptations. KIF1A has a region containing an elongated loop 12 (L12 region) within its motor core. This loop contains an insertion referred to as the “K-loop” due to the presence of multiple tandem lysine residues (6). This positively charged region of L12 bestows KIF1A with an extremely high MT on-rate due to its presumed interaction with the highly negatively charged tubulin C-terminal tail domains (3, 7). The entire K-loop has never been visualized in any reported KIF1A structure, implying that it is partially disordered in all states of the motor’s mechanochemical cycle observed thus far. Therefore, it is currently unclear whether the entire K-loop must adopt a specific conformation or orientation, with respect to the MT surface, to effectively enhance the kinesin-MT association.

KIF1A has garnered much recent attention due to the fact that more than 100 human mutations have been identified within the motor that lead to a group of developmental and degenerative neurological diseases now referred to as KIF1A-associated neurological disorder (KAND) (8). Within the spectrum of KAND phenotypes, many mutations were previously characterized to lead to phenotypes resembling hereditary spastic paraplegia (HSP), a degenerative nervous system disorder resulting in progressive lower limb spasticity (9, 10). Mutations in another transport kinesin, KIF5A, also result in HSP in humans (11). Given the large number of mutations mapped within KIF1A, it has become imperative to understand the molecular consequences of these alterations to the motor in efforts toward advancing a therapeutic strategy. Most of the KIF1A missense mutations map to the conserved motor domain (8), and several previous studies have characterized the molecular defects that result from some of these alterations (1215). While the negative consequences of several mutations in highly conserved residues known to be important for kinesin’s enzymatic activity or MT-binding properties could be reasonably predicted, many mutations remain uncharacterized.

We recently found that several KIF1A mutations in the motor domain do not result in impaired motor motility, but rather result in overactive motors, presumably due to a disruption of KIF1A’s ill-defined autoinhibition mechanism (14). Given this finding, it is imperative to understand the molecular phenotypes of individual KIF1A mutations before any therapeutic attempt. Working with the grassroots patient advocacy group, we recently became aware of a novel KIF1A missense mutation, P305L, which lies within a highly conserved portion of the L12 region and immediately adjacent to the positively charged K-loop insertion. Patients with the P305L mutation have developmental delay, cerebellar atrophy, ataxia, and eye movement abnormalities, which are hallmarks of KAND (16). When this mutation was first discovered, there was no molecular information about the role of this highly conserved proline residue in the kinesin motor mechanism, and its proximity to the K-loop implied that it could play a role in modulating the activity of this critical structural element. A recently published report (16) found that the mutation impaired KIF1A motor activity in cells and in multimotor gliding assays, but a mechanistic understanding of the effects of this mutation on KIF1A motor activity is still lacking. There are now at least seven children diagnosed with this specific P305L mutation, with substitutions by other amino acids not noted at this position (8). These observations indicate that it is a common variant within the growing KAND population and pointing to an apparent notable preference for leucine in the substitution at this position. Intriguingly, a mimetic mutation of the analogous residue in KIF5A (P278L) results in HSP in humans (17), suggesting that this proline is part of a critical element for the conserved kinesin mechanochemical cycle.

The P305 residue within KIF1A is part of a highly conserved sequence motif (PYRD/E), which we here, and others (18), find to adopt a 310-helical conformation in many families of kinesin motors from animals to fungi. 310 helices differ from α helices in the arrangement of their backbone hydrogen bonding (with 10 atoms in the ring formed by making the H-bond), giving 310 helices 3, instead of 3.6, residues per turn. This arrangement results in tighter winding of the helix and repositioning of side chains with respect to the more common α helix. 310 Helices, which are more rare and are thought to be inherently more labile than α helices (1923), are typically short and have been proposed to act as intermediates in the folding/unfolding of α helices (24). In addition, proline itself is an anomalous amino acid owing to its five-membered ring within the polypeptide backbone, with ring-locked nitrogen unable to act as a hydrogen bond donor. Functionally, conserved prolines have been described to act as dynamic, flexible hinges that mediate propagation of conformational changes from one domain in a protein to another, such as in the activation mechanism of G protein–coupled receptors (25). In addition, helix distortion by prolines has been shown to mediate key mechanistic conformational changes, for example, in the voltage-gating mechanism of connexin32 (26). Thus, P305’s position at the N-terminal cap of the PYRD/E 310 helix may bestow this unique element with additional functional properties (see below).

Prior mutagenesis studies of charged residues within this sequence suggest that it plays a critical role in the kinesin-MT interaction, although mutation of the analogous proline in KIF5B (P276) to alanine, which is less bulky than leucine, has little effect on the Km for MTs or on the MT gliding rate of the motor (27). It is unknown how this KIF5B (P276A) mutant motor behaves under resistive load. In certain Mg–adenosine diphosphate (ADP)–bound KIF1A structures, residues in the PYRD sequence deviate from the 310 helix and adopt other nonhelical conformations (e.g., hydrogen-bonded turn), which we discuss further in Results below. Notably, KAND mutations are found in three of the four residues that make up this 310 helix in human KIF1A (P305L, Y306C, and R307G/P/Q), HSP mutations in two of these residues in human KIF5A (P278L and R280H/C/L), and one in KIF1C (R301G) (8, 17, 2830). These observations highlight the importance of this structural element in kinesin function and human disease.

Here, we perform a comprehensive analysis of the P305L variant in KIF1A using genetic, biochemical, and single-molecule methods. We find that the mutation cannot rescue the loss of KIF1A activity in a genetic model system, implying that it results in a complete loss of function in living cells. While the mutation reduces the velocity, run length, and force generation of homozygous mutant motors in vitro, these effects are dwarfed by a massive defect in the MT association rate of the motor, particularly in the weak-binding ADP state of the motor. These results are consistent with a role of the 310 helix in modulating the activity of kinesin’s L12 region/K-loop, a critical MT-binding element. Mutation of the analogous residue in the orthogonal kinesin-1 (KIF5) family results in an even larger defect in MT association, providing new insight into the molecular basis of the HSP mutation P278L found in KIF5A. Together, our results lend support to the hypothesis that a transient conformation of the L12/K-loop, not just its mere presence (31, 32), is critical to enhance the motor’s MT affinity during the motor’s MT-binding cycle. More broadly, we identify a highly conserved 310-helical element, within the L12 region, that is critical for the affinity of the motor for MTs. With its effect on MT affinity, it contributes to the motor’s high MT on-rate and its ability to move and generate force, highlighting an understudied aspect of the kinesin-MT interface.


A genetic model reveals that KIF1AP305L behaves as a null mutation in vivo

To characterize the molecular defects associated with the P305L mutation in KIF1A, we first used a well-characterized genetic model system in Caenorhabditis elegans. In this system, the worm homolog of KIF1A, unc-104, is inactivated by a point mutation within the cargo-binding PH domain located in the distal C-terminal tail region of the motor [unc-104(e1265)]. The inability of the motor to bind to cargo results in degradation of the protein via the ubiquitin pathway (33). The loss of KIF1A-cargo binding and reduction in motor protein levels results in the “uncoordinated” movement phenotype in which mutant worms are unable to move on agar plates [mean velocity for wild-type (WT) and unc-104(e1265), 5.4 ± 1.2 and 0.5 ± 0.3 mm/min, respectively; Fig. 1B]. We have previously shown that introduction of the human KIF1A gene into unc-104(e1265) background results in restoration of movement to near WT levels (14), indicating that the human gene can largely compensate for unc-104’s cellular functions in worms. Single-molecule studies with recombinant proteins show that UNC104 and KIF1A have similar motile and force generation properties (15).

Fig. 1 Characterization of KIF1AP305L in a C. elegans model.

(A) Cartoon schematic showing the experimental approach. Ablation of the C. elegans homolog of KIF1A, unc-104, leads to the uncoordinated phenotype in which mutant worms are unable to move robustly. In this genetic background, introduction of a WT human KIF1A gene partially rescues animal movement. Human KIF1AP305L was introduced and assayed for its ability to rescue animal motility. (B) The velocity of the worm movement is plotted for each genetic background. Three independent lines were assayed for human KIF1A, and two independent lines were assayed for human KIF1AP305L. Note that while human KIF1A rescues worm movement to approximately half of the normal worm velocity, KIF1AP305L is unable to do so. Data points represent individual worms. Statistical differences between conditions were assessed by Kruskal-Wallis test. ns, not significant; ***P ≤ 0.001, ****P ≤ 0.0001.

We created three independent rescue lines using WT human KIF1A and two independent rescue lines using human KIF1AP305L and assayed the resulting animals for movement phenotypes on agar plates. Consistent with our previous results, expression of human KIF1A rescued animal movement to approximately 50% of WT velocity (Fig. 1B). While this rescue is weaker than we previously observed (14), the phenotype may correlate with gene expression levels, which are likely variable in our lines. In contrast to WT KIF1A, transgenic expression of KIF1AP305L did not rescue movement defects (Fig. 1B), indicating that the P305L mutation results in near complete loss of KIF1A motor function within living cells. These results strongly suggest that the KAND phenotype in humans is driven by loss of KIF1A motor function in cells.

The P305L mutation negatively affects KIF1A’s mechanochemistry

The evolutionarily conserved P305 residue lies immediately C-terminal to the K-loop within the L12 region of the KIF1A motor domain (Fig. 2). The K-loop has not been directly visualized in any prior structural studies of KIF1A, suggesting high structural heterogeneity in both MT-bound and unbound states, in contrast to the shorter loop L12 in KIF5B, which has been resolved in published structures (34). We modeled the missing KIF1A K-loop, which is shown for visual comparison in the context of P305, to L12 in KIF5B and its equivalent residue P276 (Fig. 2, A and B). In our pseudomodel of KIF1A, the K-loop is visualized with its 12 additional residues, 6 of which are positively charged lysines (Fig. 2C); it also bears a flanking proline distal to P305, at position 292, which does not acquire secondary structure in published studies (Fig. 2C) and is not observed to be mutated in patients with KAND (8). The additional length and charge of the K-loop may bring it in close proximity to the highly negatively charged (acidic) C-terminal tail of β-tubulin (Fig. 2A, star) and confer motor properties distinct from other kinesins. The P305 residue in KIF1A (Fig. 2A) and P276 in KIF5B (Fig. 2B), as well as equivalent proline residues in other kinesins (not shown), orient similarly with respect to tubulin. This suggests functional conservation across diverse kinesin families, which do not bear lengthy loops in the L12 region. Inspection of high-resolution kinesin motor domain structures revealed that the highly conserved PYRD/E sequence motif folds into a 310 helix in many different classes of kinesin (fig. S1 and Fig. 2C), in agreement with a previous assignment of this helix in a structure of fungal kinesin-3 (18). Mutation of P305, or the equivalent proline in other kinesins, possibly disrupts the ability of the region to fold as a labile 310-helical structure. In the case of KIF1A, the mutation may disturb favorable orientation of the K-loop with respect to the C-terminal tail of β-tubulin, or it may interfere with unique properties conferred upon the motor by this extended and charged element during its mechanochemical cycle.

Fig. 2 Visualization of the location of the P305 residue and 310 helix within the kinesin motor domain.

(A and B) KIF1A [yellow; Protein Data Bank (pdb): 1vfx], with K-loop/L12 (cyan-green; 288-303) modeled via Swiss-Model (55) and shown for comparison to loop L12 in KIF5B (green; pdb: 4hna). */star, β-tubulin C terminus. 310 helix (red); surrounding α helices: α4 and α5. P305 in KIF1A and corresponding P276 in KIF5B are shown as sphere representations (orange). (C) Sequences of motor domains with available structures were aligned using ClustalW (56). Residues surrounding the 310 helix are shown. Dashed line denotes the original designation of L12, although we show here that the PYRD sequence most often folds into a 310 helix and is thus not a “loop” by conventional definition. Annotation (left): gene name, species abbreviation, pdb id. Right: KIF1A magnesium (Mg)–nucleotide–bound form. Species: Hs/Homo sapiens, Rn/Rattus norvegicus, Mm/Mus musculus, Dm/Drosophila melanogaster, Gi/Giardia intestinalis, Nc/Neurospora crassa. Assignment of secondary structure was done using Procheck (57, 58) according to the method of Kabsch and Sander (59). Background coloring: α helix (blue), 310 helix (orange), hydrogen-bonded turn (yellow), bend (green), without assignment (white), and residues not available in pdb (gray).

We aligned all available high-resolution structures of KIF1A spanning several carefully studied states corresponding to the motor’s nucleotide hydrolysis cycle (Fig. 2C). The 310 helix is present in most states observed. Notably, in two KIF1A-Mg-ADP transition states, corresponding to the motor undergoing Mg release upon binding to the MT [2zfj/T1 and 2zjk/T2 (35); Fig. 2C], the proline-phi torsion angle for P305 is 3 SDs outside normal (not shown). Proline’s atypical restrictions in phi-psi space arise from its five-membered ring, which limits rotation about the N-αC bond in the polypeptide backbone. Thus, what corresponds to a captured state with PYRD in nonhelical form and an unusually high proline-phi torsion angle may be indicative of a structural element under strain or allosteric regulation. Together, this would suggest that the unique PYRD 310 helix may act as a labile structural element, or temporal regulatory switch, that is critical for specific steps, which may couple to the motor’s mechanochemical cycle, or for helping to tether the motor head when the kinesin is under load. The PYRD/E sequence motif also adopts a 310-helical conformation in structures from other kinesin families and species examined (fig. S1 and Fig. 2C).

On the basis of this analysis, it is possible that mutation of P305 could directly affect KIF1A’s interaction with the MT, although pseudoatomic models fit to the electron density of KIF1A bound to MT would not suggest direct contact (36). We have previously reported that some human disease mutations within the KIF1A motor domain do not disrupt the motor’s mechanochemical cycle, but rather impair the autoinhibition mechanism of the full-length motor (5, 37, 38), leading to excessive motor activity, which also appears to lead to KAND (14). Thus, we hypothesized that the P305L mutation would either directly affect the motor’s mechanochemical cycle or, possibly, disrupt the autoinhibition mechanism of KIF1A. These hypotheses have disparate predictions; the first would result in decreased motor activity, while the latter increased motor activity. Another possibility we considered is that the mutation disrupts the three-dimensional folding of the motor domain, leading to unstable or aggregated protein, and thus a loss of KIF1A activity, or even possibly a toxic gain of function, in cells.

To distinguish between these possibilities, we first turned to single-molecule assays using full-length, recombinant, and purified KIF1A motors (14). The full-length motor has a relatively low MT landing rate, compared with the more widely studied tail-truncated and constitutively active motor. This is presumably due to autoinhibition of the full-length motor, although mechanistic details of KIF1A’s mechanism of autoinhibition remain unclear (5, 37, 38). Using baculovirus expression, we purified full-length KIF1A and KIF1AP305L and assessed their structural integrity using size exclusion chromatography (SEC). Both purified motors eluted from the SEC column indistinguishably (Fig. 3A). These results argue against a deleterious effect of the P305L mutation on protein folding or stability. Next, we used multicolor, single-molecule total internal reflection microscopy (TIRF-M) to directly visualize the motor activity of our purified motors. As we previously observed, WT KIF1A moved long distances along MTs in the presence of ATP (Fig. 3B). Unexpectedly, we also observed long-distance movement of KIF1AP305L (Fig. 3B), ruling out the possibility that the mutation abolishes motor activity. We measured the velocity of these movements and observed that the P305L mutation leads to an ~25% decrease in velocity [1175 ± 528 nm/s versus 876 ± 479 nm/s (±SD) for KIF1A and KIF1AP305L, respectively; Fig. 3C]. In addition, we noted an ~50% decrease in motor run lengths [2.5 ± 0.3 μm versus 1.2 ± 0.2 μm (±SD) for KIF1A and KIF1AP305L, respectively; Fig. 3D]. These data reveal that the P305L mutation does not disrupt protein folding or stability, but rather results in impaired motility of the KIF1A motor.

Fig. 3 Characterization of the KIF1AP305L mutation using full-length motors.

(A) SEC chromatogram showing elution profiles of full-length KIF1A (magenta) and KIF1AP305L (green). Elution positions of prep contaminants (Contam.) and full-length KIF1A are noted. Below: Coomassie-stained SDS–polyacrylamide gel electrophoresis (PAGE) gel of the column elution fractions. (B) Kymograph from TIRF-M movie showing both KIF1A (magenta) and KIF1AP305L (green) motors moving along the same MT. Equal concentration of each motor was added to the TIRF chamber. (C) Measured velocity distribution of full-length KIF1A motors (N = 2 independent trials and n = 280,270 motors from KIF1A and KIF1AP305L, respectively). ****P< 0.001. (D) Cumulative frequency plot of the measured run lengths of WT and P305L motors. Connecting lines show fit to a one-phase exponential decay function (R2 = 0.99 and 0.98 for KIF1A and KIF1AP305L, respectively). The characteristic run length derived from the fits (τ) is displayed (N = two independent trials and n = 207,241 for KIF1A and KIF1AP305L, respectively).

The P305L mutation most markedly affects KIF1A’s initial MT interaction

While prior studies have found defects in the velocity and run lengths of mutant motor proteins in vitro (39, 40), it is currently unclear how important these biophysical parameters actually are for motor protein function in vivo. For instance, while KIF1A is ultraprocessive on bare MTs in vitro, recent evidence suggests that nonmotor microtubule-associated proteins (MAP) (41), as well as other motor proteins, on the same MT (42) can markedly affect the motile parameters of KIF1A and other motor proteins. Given the relatively modest effects we observed for the P305L mutation on the velocity and run lengths of full-length KIF1A motors in vitro (Fig. 3), we wondered whether these defects could account for the marked phenotypes observed in humans with this mutation. The aforementioned results are complicated by the fact that we still do not fully understand how full-length KIF1A motors are autoinhibited or how that autoinhibition is relieved in vivo or in vitro. Thus, we turned to a well-characterized KIF1A construct in which the entire tail domain is removed, and the motor is stably dimerized via fusion to a leucine zipper (KIF1A 1-393-LZ). This KIF1A construct is constitutively active, generates the same force as full-length KIF1A, and has a high MT landing rate due to the lack of autoinhibition elements located in the tail domain (5, 15, 37, 38).

We purified KIF1A 1-393-LZ proteins from baculovirus-infected insect cells and assessed protein folding via SEC. Both WT and P305L motors eluted similarly from the column (Fig. 4A), further indicating that the P305L mutation does not grossly perturb the folding of the KIF1A motor domain. We assessed the ability of these motors to interact with and translocate along MTs using our multicolor TIRF-M assay. We mixed differentially labeled WT and P305L mutant motors and observed their movement within the same TIRF chamber, along the same MTs, providing a robust internal control for the assay conditions. Because the MT-binding rate of this truncated motor is very high due to removal of the autoinhibition mechanism, we used an ~30-fold lower concentration of WT motor as compared with our assays with full-length KIF1A (Fig. 3). However, at these low concentrations, while we could observe many motile WT motors, we could not detect any mutant motors moving along MTs (not shown). Therefore, we increased the concentration of KIF1AP305L motors by 10-fold (as compared with WT; Fig. 4B). In these conditions, we could observe the movement of both types of differentially labeled motors moving along the same MTs in the chamber, although the number of moving KIF1AP305L motors was clearly lower than that of the WT motors (Fig. 4B).

Fig. 4 Characterization of the KIF1AP305L mutation using truncated, constitutively active motors.

(A) SEC chromatograms for WT (magenta) and P305L truncated (green), dimerized motors (1-393-LZ). Elution positions of prep contaminants and truncated KIF1A are noted. Below: Coomassie-stained SDS-PAGE gel of the column elution fractions encompassing the motor peak. (B) Kymograph from a TIRF-M movie showing both KIF1A (magenta) and KIF1AP305L (green) moving along the same MT. Note the difference in motor concentration. (C) Measured velocity distribution of 1-393-LZ KIF1A motors (N = 2 independent trials and n = 161,116 motors from KIF1A and KIF1AP305L, respectively). (D) Cumulative frequency plot of the measured run lengths of WT and P305L 1-393-LZ motors. Connecting lines show fit to a one-phase exponential decay function (R2 = 0.99 for both KIF1A and KIF1AP305L, respectively). The characteristic run length derived from the fits (τ) is displayed (N = 2 independent trials and n = 142,129 for KIF1A and KIF1AP305L, respectively). (E) Measured number of processive motors per unit length of MT and time (N = 2 independent trials and n = 12 MTs analyzed each for KIF1A and KIF1AP305L). For all panels, ***P ≤ 0.001 and ****P ≤ 0.0001.

Inspection of the resulting kymographs revealed that the slopes of motile KIF1AP305L appeared shallower, indicating that the mutant motors were moving at reduced velocities, consistent with our results with full-length motors (Fig. 3). Quantification of motor velocities confirmed that the P305L mutation impaired motor velocity by approximately 50% [1352 ± 650 nm/s versus 641 ± 368 nm/s (±SD) for KIF1A and KIF1AP305L, respectively; Fig. 4C]. These results are consistent with the results we obtained with full-length motors (Fig. 3). In addition, we measured the run lengths of the truncated motors and observed a more modest ~25% decrease for the mutant motors [2460 ± 67 nm versus 1803 ± 210 nm (±SD) for KIF1A and KIF1AP305L, respectively; Fig. 4D], similar to our results with full-length KIF1A motors (Fig. 3). It is interesting to note that the magnitude (but not the trend) of the effects of the P305L mutation on velocity and processivity differ between full-length (Fig. 3) and tail-truncated motors (Fig. 4). We hypothesize that these biophysical differences are attributable to biochemical distinctions bestowed by the autoinhibition mechanisms of full-length motors.

The initial motor-MT interaction of the tail-truncated motor is not complicated by the autoinhibition mechanism present in full-length motors, allowing us to directly compare the number of motile motors on individual MTs within the same imaging chamber. As inferred by our initial observations of differential motor concentrations required for observation of motile molecules (see above), we measured a very marked decrease in the numbers of moving molecules along MTs for the P305L construct (Fig. 4E). This ~97% (71-fold) drop in motor landing rate was much larger than the ~50% decrease in velocity or ~25% drop in processivity. Thus, the P305L mutation results in relatively modest defects in KIF1A’s motor biophysical output once it is moving processively along MTs, but a precipitous decline in the initial motor-MT interaction, implying that the KAND phenotype (as well as the null phenotype we observed in our worm model) may largely be due to the inability of the mutant motor to get onto the MT. The K-loop of KIF1A has been reported to be critical for the motor’s MT on-rate, but not for its movement (3), suggesting that the largest observed defect of KIF1AP305L could be the result of impaired K-loop function.

The P305L mutation impairs K-loop function in the ADP state

It has been previously reported that the K-loop is critically important for the KIF1A-MT interaction during the weak binding state of the motor’s mechanochemical cycle (the ADP-bound state) (3, 32, 35). Swapping the KIF1A K-loop with the less positively charged L12 from KIF5C increased the dissociation constant (Kd) for MTs by ~4-fold (32), while single-molecule studies confirmed that mutation of the K-loop abolished the interaction of ADP-bound KIF1A with MTs (3). The interpretation of these results is that the positively charged K-loop interacts with the nearby negatively charged C terminus of β-tubulin to facilitate the KIF1A-MT interaction (Fig. 2A).

Thus, we examined the effect of the P305L mutation on the interaction of truncated KIF1A dimers, in their weak binding ADP state, with MTs using single-molecule imaging. We again noted a large difference in the concentration dependence of motors interacting with MTs between WT and KIF1AP305L motors (Fig. 5A). Quantification of the motor landing rates revealed an ~83% reduction in landing rate for KIF1AP305L motors in the ADP state (Fig. 5B). Measurement of the motor dwell times on MTs in this state revealed a milder ~27% decrease in dwell time for KIF1AP305L versus WT motors in ADP (Fig. 5C). To examine whether the change from proline to leucine affects KIF1A simply due to the sterics of the leucine side chain, we also mutated P305 to tryptophan (P305W), a more bulky, but similarly hydrophobic, residue as leucine. We assayed this mutant motor’s ability to interact with MTs in ADP. While KIF1AP305W did show reduced landing onto MTs in ADP, the landing rate was not as markedly reduced as observed for KIF1AP305L (54% versus 83% reduction for P305W and P305L, respectively; Fig. 5B). The dwell time of KIF1AP305W motors was very similar to WT motors {0.93 ± 0.05 s versus 0.98 ± 0.05 s [95% confidence interval (CI)] for WT and P305W, respectively} and markedly different from KIF1AP305L motors [0.64 ± 0.03 s (95% CI); Fig. 5C]. Therefore, we conclude that the P305L mutation markedly affects the motor’s landing rate in a manner that is specific to the leucine side chain. Furthermore, because the dwell time of the KIF1AP305W is unaffected by the mutation, we conclude that the less bulky leucine residue is not likely to sterically clash with the main MT-binding element of the motor, the α4 helix. If this were the case, we expect the tryptophan residue to also cause a strong decline in the dwell times of the motors due to disruption of the MT-binding interface. Thus, these data support the hypothesis that the P305L mutation primarily affects the ability of L12 and its K-loop insert to facilitate the initial motor-MT interaction. In further support of this hypothesis, by measuring the steady-state adenosine triphosphatase (ATPase) rates of the motors, we observed a large increase in the Km for KIF1AP305L (Fig. 5D), further demonstrating a strong defect in MT association. Because the Km approximates the MT affinity of kinesin in the ADP state (27), we conclude that the P305L mutation primarily affects the motor’s MT association rate in the ADP state.

Fig. 5 Characterization of the weak MT-binding state of KIF1A.

(A) Kymographs from TIRF-M movies showing binding and dwell events of 1-393-LZ motor constructs in 2 mM ADP. Note the different protein concentrations used. (B) Quantification of the landing rate for KIF1A and KIF1AP305L or KIF1AP305W motors (N = 2 independent trials and n = at least 12 MTs analyzed each for each motor). (C) Cumulative frequency plot of the measured dwell times of WT and P305L 1-393-LZ motors. Connecting lines show fit to a one-phase exponential decay function (R2 > 0.99 for all fits). The characteristic dwell time derived from the fits (τ) is displayed (N = 2 independent trials and n = 196, 221, and 270 for KIF1A, KIF1AP305L, and KIF1AP305W, respectively). (D) Steady-state ATPase assays for KIF1A and KIF1AP305L. Plotted are the mean values from at least two to three independent trials per concentration of MTs, and error bars are SEM. Nonlinear fits to the Michaelis-Menten equation are shown, and the calculated Km and Vmax are displayed in the table to the right with 95% CI errors shown. Note that the errors of the fit for KIF1AP305L cannot be accurately calculated by this method (ud, undetermined).

These results are consistent with a prior model that proposes that the K-loop primarily functions to endow KIF1A with a high MT association rate during its weak binding (ADP) state (3). However, our results reveal that the presence of the positively charged region of the K-loop is not sufficient for this function, and we posit that the conformation of the L12 region, transiently constrained by a labile 310 helix and modulated by the atypical properties of the proline residue, at the N-terminal cap of the 310 helix, is required for this function. Notably, three of the four residues that make up the PYRD 310 helix are mutated in patients with KAND (8), and we hypothesize that such mutations (Y306C and R307G/P/Q), which may destabilize this unique helix, are likely to exhibit effects on the KIF1A-MT interaction that are similar to P305L. However, patients with mutations in different positions in this helix, and multiple patients with mutations in the same position, exhibit varying degrees of disease severity (8), which suggests nuanced effects on the motor’s MT functions or developmental or other effects in vivo.

The function of the 310 helix is conserved in different classes of kinesin motors

The P305 residue in KIF1A is part of a highly conserved PYRD/E sequence found in many other classes of kinesin motors in humans and other organisms (Fig. 2). This sequence adopts a 310-helical conformation in most of the published kinesin structures examined. In some structures, residues in the PYRD/E sequence deviate and adopt other nonhelical conformations (Fig. 2C). The high sequence conservation observed and the preference to adopt a 310-helical conformation imply that this structural element plays an important role in the basic kinesin translocation mechanism. The canonical kinesin-1 family (KIF5A, KIF5B, and KIF5C) is probably the most well-studied kinesin motor, and members of this family also contain the conserved PYRD sequence motif within L12 of the motor domain (Fig. 2C). Notably, the KIF5 family does not contain a highly charged K-loop like KIF1A, resulting in an overall shorter L12 (Fig. 2). We mutated the analogous residue in KIF5B, P276, to leucine to assess the effects of this mutation on KIF5B’s motile properties. We measured the binding of a tail-truncated, fluorescently tagged KIF5B motor (amino acids 1 to 420) to MTs in the presence of ATP. The WT motor bound robustly to MTs in the presence of ATP (Fig. 6A) and moved processively (Fig. 6B), as previously characterized by many laboratories. Notably, KIF5BP276L showed little observable binding to, or movement along, MTs at two different concentrations spanning an order of magnitude (Fig. 6, A and B). Quantification of the fluorescence intensity of kinesin on MTs in ATP revealed an enormous decrease of ~4 to 5 orders of magnitude in fluorescence intensity for the KIF5BP276L motor (Fig. 6C) to near background levels, indicating an almost complete loss of the kinesin-MT interaction. The near complete lack of binding to MTs was distinctly worse than the effects we observed with KIF1AP305L (Figs. 3 to 5), prompting us to investigate whether KIF5BP276L was even capable of interacting with MTs. However, in the presence of the nonhydrolyzable ATP analog, AMP-PNP, we observed robust binding of KIF5BP276L to MTs (Fig. 6A), indicating that the motor is still capable of interacting with MTs in this particular state. Together, our data reveal that the conserved 310 helix within L12 in multiple kinesin families plays a crucial role in L12’s ability to facilitate the interaction of the kinesin motor domain with the MT surface, particularly in the ADP state of the mechanochemical cycle.

Fig. 6 Characterization of conserved proline mutation in KIF5.

(A) Identically scaled TIRF-M images showing MTs (blue) and KIF5 molecules (magenta) in ATP at two different protein concentrations. Note the lack of MT binding for KIF5P276L. KIF5BP276L binds robustly to MTs in the presence of AMP-PNP, demonstrating that the motor is still proficient at binding. (B) Kymographs from TIRF-M movies of KIF5B motors in ATP demonstrate processive movement along MTs (diagonal lines) for KIF5B, but not for KIF5BP276L. Only transient binding events are observed for KIF5BP276L. (C) Quantification of mean fluorescence intensity of KIF5B motors along MTs in the presence of ATP at two different protein concentrations (N = 2 independent trials and n = 20 to 35 MTs quantified per condition). a.u., arbitrary units.

The P305L mutation impairs KIF1A’s ability to generate force along MTs

After determining the effects of the P305L mutation on the KIF1A-MT interaction and KIF1A motility in the absence of load, we wondered whether the mutation might have any effects on the ability of KIF1A to generate force along MTs, which is of particular importance for the KIF1A-powered displacement vesicular cargo within living cells. To assess any effects on force generation, we performed single-molecule optical tweezers assays (7, 43, 44) with our human KIF1A proteins. In a recent study (15), we have shown that full-length rat KIF1A and tail-truncated rat KIF1A (1-393)-LZ both detach before reaching a stall plateau (maximal sustained force generation) at an average load of ~2.7 pN and then rapidly reattach to the MT to resume motion, resulting in a sawtooth-like force generation pattern in which force generation events cluster tightly together (15). We find that human KIF1A (1-393-LZ), which differs from a similar rat KIF1A construct by a single amino acid (valine instead of an isoleucine at residue 359), also exhibits a sawtooth-like force generation pattern (Fig. 7A) but detaches at a reduced average force of 2.2 (1.9, 2.5) pN [median (quartiles); Fig. 7E]. In contrast to human WT KIF1A, KIF1AP305L detaches at an ~4-fold reduced force of 0.6 (0.5, 0.8) pN (Fig. 7, B and E), revealing an even greater effect on force generation than on velocity and processivity (Figs. 4 and 7). These results are consistent with our observations that the mutation markedly impinges on the motor’s ability to bind to the MT (Figs. 3 and 4). Thus, we conclude that the 310 helix plays a critically important role in KIF1A’s ability to generate force and move under resistive loads. Considering that L12 is still intact in the mutant motors, the data further suggest that the conformation of L12, not its mere presence, is crucial for its role in promoting the kinesin-MT interaction during force generation.

Fig. 7 Characterization of the force generation properties of KIF1AP305L and KIF5BP276L.

(A to D) Representative force versus time records of bead movement driven by single molecules of (A) WT KIF1A (1-393)-LZ, (B) KIF1AP305L (1-393)-LZ, (C) WT KIF5B (1-420), and (D) KIF5BP276 (1-420). (E) Detachment forces. Green bars indicate the median values with quartiles. WT KIF1A (1-393)-LZ: 2.2 (1.9, 2.5) pN, N = 1737; KIF1AP305L (1-393)-LZ: 0.7 (0.5, 0.8) pN, N = 637; WT KIF5B (1-420): 3.0 (2.4, 3.4) pN, N = 603; KIF5BP276 (1-420): 1.7 (1.1, 2.2) pN, N = 415. Statistical significance was determined using an unpaired Welch’s t test (****P < 0.0001). (F) Maximal force (“stall force”) sustained during a single run against load for a minimum time duration of 10 ms [3.1 (2.7, 3.5) pN, N = 405], 20 ms [3.1 (2.7, 3.4) pN, N = 381], 50 ms [3.2 (2.7, 3.4) pN, N = 262], and 100 ms [3.2 (2.8, 3.5) pN, N = 154], respectively. (G) Stall force of WT KIF5B (1-420) (≥20-ms criterion).

Last, to define whether the 310 helix is also involved in the force generation of kinesin-1, we performed optical trapping experiments on WT and P276L tail-truncated KIF5B. We find that WT KIF5B shows stalling events as expected for a kinesin-1 motor but does so at an average force of 3.2 ± 0.5 pN (mean ± SD; ≥20 ms criterion; Fig. 7, C and E to G), which is less than the previously reported maximal force generation of 5 to 6 pN of full-length kinesin-1 and the widely studied KIF5B (1-560) construct (4549). Even if we apply a stalling criterion of 100 ms, the stall force remains at 3.2 ± 0.4 pN (Fig. 7F). We hypothesize that this difference could be due to the shorter KIF5B (1-420) construct used in this work. In support of this idea, using the same higher pH buffer (pH 7.2) as used here, we recently measured a stall force of 4.61 ± 0.01 pN (±SEM) for a longer KIF5C (1-560) construct (15). As most prior studies on kinesin force generation used nonphysiological acidic pH buffers (typically pH ~6.8), and as previous data revealed that the interaction of kinesin with MTs is highly sensitive to pH (50), we conclude that the lower stall force of KIF5B (1-420) is caused by the shorter construct length and the use of a more physiological buffer. In addition, a recent study has shown that a vertical force component causes premature detachments of kinesin-1 from MTs (51). It is therefore possible that the shorter construct, which forms a larger angle with the trapping bead and MT surface, stalls at a lower force as a result of an increased vertical force component. Further studies are necessary to determine the effects of pH and trapping geometry on KIF5 force generation.

Nonetheless, a comparison of the average detachment forces of human WT KIF5B and KIF5BP276L [3.0 (2.4, 3.4) pN versus 1.6 (1.1, 2.2) pN, median (quartiles); Fig. 7E] revealed an ~50% reduction in force generation, demonstrating that the 310 helix segment is also critically important for the force generation of kinesin-1. Our results thus reveal that the highly conserved 310-helical element within L12 plays important roles under load in kinesin motors of distant evolutionary lineage. Furthermore, these results provide unifying insight into the molecular mechanism underlying 310 helix mutations that cause KAND in KIF1A and HSP in KIF5A.


Disruption of long-distance transport by kinesin motor proteins is becoming recognized as a prominent driver of neurological diseases such as HSP, KAND, and Rett syndrome. The sheer number of reported KIF1A mutations resulting in KAND and HSP phenotypes complicates the planning and development of effective therapeutics to treat these disorders. Having a molecular understanding of the defects caused by particular mutations or clusters of mutations that fall within similar structural regions of the motor would greatly enhance therapeutic strategies. Here, we use single-molecule methods to dissect the specific defects in an understudied pathological variant of KIF1A, P305L, demonstrating that single-molecule observation, along with traditional bulk biochemical assays and genetic rescue experiments, is a powerful platform to understand the impacts of disease mutations on molecular function. Our work unexpectedly revealed that a highly conserved sequence that is absolutely critical for the kinesin-MT interaction adopts a labile 310-helical conformation and is a structural locus susceptible to recurring human disease mutations in kinesins.

A functional conformation of kinesin’s L12/K-loop may be critically mediated by the adjacent 310 helix

Using deletion or replacement mutagenesis, several studies have found that the presence of the highly charged K-loop within the KIF1A motor domain is critical for its function as a long-distance transport motor by mediating a high MT-binding rate during the weak-binding (ADP) state of the motor’s hydrolysis cycle (3, 6, 32, 35). However, despite a wealth of structural knowledge of the KIF1A motor domain, the K-loop has never been visualized, presumably because of conformational flexibility. The K-loop follows the main MT-binding element made up of loop 11 (L11) and the α4 helix on the bottom of the kinesin motor domain (32, 36). Crystallography of monomeric KIF1A motor domains in the absence of tubulin (32) found the conformation of α4 changes during the hydrolysis cycle of the motor with the C-terminal end of α4, near the K-loop, elongating in the ADP-Pi state, presumably altering the conformation of the attached K-loop. Release of phosphate results in partial melting of the C-terminal end of α4, again presumably altering the conformation of the attached K-loop to allow for its interaction with the C terminus of β-tubulin (32). Furthermore, proteolytic mapping of the kinesin motor domain in different nucleotide states also revealed nucleotide-dependent changes in L12, confirming conformational plasticity in this region (31). These data support a model whereby the conformation of L12 is dynamic and directly connected to the ATP hydrolysis cycle of kinesin.

More recently, ~7-Å cryo–electron microscopy structures of KIF1A bound to MTs, in several states corresponding to the hydrolysis cycle, reveal neither the conformation of the positively charged portion of the K-loop nor the negatively charged C-terminal tubulin tail (36), indicating structural heterogeneity in these regions. However, on the basis of the fitting and calculation of the pseudoatomic models, these structures did reveal electron density between helix H12 of β-tubulin and parts of the calculated location of the PYRD 310 helix within KIF1A. While the exact composition of this density in distinct nucleotide states is unclear at present, we hypothesize that it is crucial for mediating a functional conformation of the adjacent K-loop during the weak-binding state of the motor. Density between β-tubulin and parts of the putative 310 helix is maintained in all nucleotide states observed, suggesting that it may serve as a crucial anchor point to the MT. We hypothesize that this contact may also be critical to orient the conformation of the K-loop and mediate its effects during the landing of KIF1A onto the MT. There may be less density connecting the kinesin-1 motor, KIF5A (which was modeled on the basis of KIF5B), to the MT in this same region. Yet, our results reveal that the same proline that initiates the 310 helix segment is also critical for the MT interaction and force generation of KIF5B (Figs. 6 and 7), and we suggest that it likely plays a similar role in mediating L12’s interaction with tubulin in KIF5 family motors and other kinesins (Fig. 2, B and C).

An interesting aspect of our data is that the largest effect of the P305L mutation is on the landing rate of kinesin onto the MT, highly similar to deletion or mutation of the K-loop (3, 6). Once mutant KIF1A motors get onto the MT, they are capable of taking many hundreds of steps without dissociating, suggesting that the function of the 310 helix may not be as crucial during motor stepping in the absence of resistive load. This is consistent with prior results, which found that mutation of the K-loop strongly perturbs the landing rate, but not processivity of KIF1A (3). However, while we observe more mild defects in velocity and processivity, we see more severe effects on KIF1A force generation under load, suggesting that the mutation also impairs important aspects of the mechanochemical cycle that are sensitive to resistive force. Our data support the notion that the 310 helix within L12 is as important for facilitating the landing of KIF1A onto MTs, similar to the function of the adjacent K-loop as previously reported (3). On the basis of our data, we favor the interpretation in which altering of the ability of the PYRD/E motif to act as a labile regulatory 310 helix or switch under load affects allosteric communication between loop L12, nucleotide-binding site, and MT-binding sites within the kinesin motor. However, we cannot rule out the possibility that the mutation also sterically affects the conformation of the proximal α4 helix (Fig. 2, A and B), thereby disrupting its ability to facilitate kinesin-MT interactions. Replacement of the proline with a more bulky, but also hydrophobic, residue did not have a marked effect on the motor’s landing rate in ADP, suggesting that a steric clash with the L11-α4 MT-binding module is less likely than a direct effect on the immediately proximal K-loop within L12. High-resolution structural data of mutant motors would help further distinguish between these hypotheses.

Prospects for human disease

Mutations in KIF1A result in a broad range of KAND phenotypes with varying severity (8), suggesting differing disease mechanisms based on the type of mutation in the motor. While some mutations result in a complete loss of motor activity or overactivation of motor activity (1214), we demonstrate here that the P305L mutation results in a severe loss of MT-binding affinity, but that unexpectedly, once mutant motors are properly loaded onto the MT, they are capable of processive movement under unloaded conditions. However, when subjected to load, the P305L mutation severely affects the force output of the motor. All these results suggest that potential treatment options for KAND may need to be tailored to the specific effects of the particular mutation on the motor’s biophysical outputs. In the case of P305L, therapeutic options that increase the mutant motor’s ability to interact with MTs could be a viable goal. The nonmotor MT-associated protein MAP9 was recently shown to enhance the landing rate of KIF1A in vitro (41), suggesting that orthogonal endogenous molecules could be useful targets for potential therapeutic interventions.

Three of the four residues that make up the short 310 helix are mutated in KIF1A (P305L, Y306C, and R307G/P/Q), the related KIF1 family member KIF1C (R301G), and the orthogonal kinesin family member KIF5A (P278L and R280H/C/L), leading to neurodegenerative disease phenotypes in humans (8, 17, 2830). These findings highlight the critical function of this understudied element of the kinesin motor core. The observation of the same and recurring missense mutation (proline to leucine) in analogous residues of KIF5A and KIF1A points to common implications for human health as well as kinesin motor mechanism. The apparent selectivity for the leucine may be revealing of particular attributes of a minimally functional surrogate residue at that position. It also indicates that therapeutics that address this defect in the kinesin-MT interaction could be tailored to augment or modulate the substitution and be applicable to several human diseases.

In summary, the single-molecule studies of a human disease mutation presented here have revealed a conserved structural motif that is critically important for kinesin-MT interactions. While prior studies have largely focused on the L11-α4-L12 region as the primary connection between kinesin and MTs, our results suggest that the 310-helical element within L12 may provide allosteric coupling critically important for the interaction. Our results further reveal that the presence of the K-loop within KIF1A is not sufficient for its function, lending support to the idea that a specific conformation of L12 couples to the kinesin enzymatic cycle.


C. elegans methods

C. elegans were maintained on Escherichia coli strain OP50 on nematode growth medium (NGM) agar plates at 20°C. Punc-104::human Kif1a vectors were prepared as described (14). Four nanograms of Punc-104::human Kif1a and 50 ng of Podr-1::gfp vectors were injected to unc-104(e1265) gonads by standard procedures (52). At the F1 generation, worms with visible green fluorescent protein (GFP) signal in head neurons were collected. Stable transformation was confirmed by transmission of extrachromosomal arrays to the F2 generation. Functional complementation of unc-104 by human KIF1A was assessed by the motility of worms on NGM plates. Worms with visible markers were transferred to new plates, and movement was recorded under an SteREO Discovery.V12 dissection microscope (Carl Zeiss, Jena, Germany) equipped with Orca-Flash 2.8 CMOS camera (Hamamatsu Photonics, Hamamatsu, Japan).

Recombinant human KIF1A assembly and preparation

All KIF1A constructs were cloned into pAcebac1 vectors (Geneva Biotech, Genève, Switzerland) by Gibson assembly. Complementary DNA encoding human KIF1A (GenBank: AB290172.1) was amplified by polymerase chain reaction (PCR). A DNA fragment encoding the mScarlet-2xStrepII tag was synthesized by gBlocks (Integrated DNA Technologies, Coralville, IA, USA). Full vector sequence was confirmed by Sanger sequencing. Truncated KIF1A constructs containing only the motor domain (M1-D393) were made from the amplified KIF1A gene. P305L mutations were introduced by PCR-based mutagenesis to both full-length and truncated constructs using Q5 plus DNA polymerase. Constructs containing the P305L mutation encoded a C-terminal sfGFP-2xStrepII tag. A bacmid was generated by transforming DH10EmBacY (Geneva Biotech) for all constructs. Insect Sf9 cells were maintained as a shaking culture in Sf-900II serum-free medium (Thermo Fisher Scientific) or, alternatively, in ESF media (Expression Systems) at 27°C. To prepare baculovirus, 1 × 106 SF9 cells were transferred to each well of a six-well plate. SF9 cells were transformed with bacmid DNA by Cellfectin (Thermo Fisher Scientific). The resulting baculovirus was amplified, and the P2 cell culture medium was used for protein expression. To prepare recombinant proteins, 400 ml (2 × 106 cells/ml) of cells were inoculated with P2 baculovirus stocks at a dilution of 1:100 and cultured for ~65 hours at 27°C. Cells were harvested by centrifugation at 3000g for 5 min and frozen in liquid nitrogen. Frozen cells were stored at −80°C until the purification step.

Recombinant human KIF5B assembly and preparation

All KIF5B constructs were cloned into pET28a vectors using Gibson assembly. A codon-optimized DNA sequence encoding the motor domain of human KIF5B (residues 1 to 420, UniProt P33176) was used. A DNA fragment encoding the mScarlet-2xStrepII tag was synthesized by gBlocks (Integrated DNA Technologies, Coralville, IA, USA). Full vector sequence was confirmed by Sanger sequencing. The P276L mutation was introduced by PCR-based mutagenesis to both full-length and truncated constructs using Q5 plus DNA polymerase. KIF5B constructs were transformed into BL21-CodonPlus (DE3)-RIPLcells (Agilent) for protein expression. Cells were inoculated with 1:500 of overnight culture and were grown at 37°C in 1.5 liters of LB media until optimal density at 600 nm (OD600) of 0.6. Cells were then induced with 0.1 mM isopropyl-β-d-thiogalactoside overnight (~16 hours) at 18°C. Cells were harvested by centrifugation as 3000g for 15 min and frozen in liquid nitrogen. Frozen cells were stored at −80°C until the purification step.

Purification of human KIF1A and KIF5B

For purification, 40 ml of purification buffer [50 mM tris (pH 8.0), 150 mM KCH3COO, 2 mM MgSO4, 1 mM EGTA, 10% glycerol] supplemented with 0.1% Triton X-100, 1 mM ATP, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride, and protease inhibitor mix (Promega) was used to resuspend frozen pellet that was thawed on ice. Cells were homogenized with several strokes in a dounce homogenizer and lysed by passing through an Emulsiflex C-3 (Avestin). Soluble lysate was obtained by centrifugation at 16,000g for 20 min at 4°C. The lysate was mixed with 2 ml of Strep-Tactin XT resin (IBA Lifesciences, Göttingen, Germany). The resin was washed extensively with wash buffer [50 mM tris (pH 8.0), 450 mM KCH3COO, 2 mM MgSO4, 1 mM EGTA, and 10% glycerol]. Then, protein was eluted with elution buffer [50 mM tris (pH 8.0), 150 mM KCH3COO, 2 mM MgSO4, 1 mM EGTA, 10% glycerol, and 100 mM biotin]. Eluted protein was concentrated to ~500 μl using Amicon Ultra 5 centrifugal filters (Merck, Darmstadt, Germany). The affinity-purified protein was further separated by gel filtration using a Phenomenex Yarra 3-μm SEC-4000 300 × 7.8–mm column (Phenomenex, Torrance CA) in GF150 buffer [25 mM Hepes (pH 7.4), 150 mM KCl, and 1 mM MgCl2] on an NGC Chromatography system (Bio-Rad Laboratories, Hercules, CA, USA). Peak fractions were pooled, concentrated in an Amicon filter again, and flash frozen in liquid nitrogen. Protein concentrations were assessed using a NanoDrop One (Thermo Fisher Scientific) and given as the total amount of measured fluorophore.

TIRF assays

Glass chambers were prepared by acid washing as previously described ( and double-sided sticky tape. Chambers were first incubated with PLL-PEG-biotin (0.5 mg/ml; Surface Solutions) for 10 min, followed by streptavidin (0.5 mg/ml) for 5 min. MTs were diluted in BRB80-T [80 mM Pipes, 1 mM MgCl2, 1 mM EGTA, and 5 μM taxol (pH 6.8)] buffer. Taxol-stabilized MTs were flowed into streptavidin adsorbed flow chambers and allowed to adhere for 5 to 10 min. Unbound MTs were washed away using SRP90 assay buffer [90 mM Hepes (pH 7.6), 50 mM KCH3COO, 2 mM Mg(CH3COO)2, 1 mM EGTA, 10% glycerol, biotin–bovine serum albumin (BSA) (0.1 mg/ml), K-casein (0.2 mg/ml), 0.5% Pluronic F-127]. Purified motor protein was diluted to indicated concentrations in the assay buffer with 2 mM ATP and an oxygen scavenging system composed of PCA/PCD/Trolox. Then, the solution was flowed into the glass chamber. Truncated KIF1A motors have a very high on-rate to MTs so that the assay buffer was adjusted to include 50 mM KCl to compensate for this in the experiments shown in Fig. 4. Images were acquired using a Micromanager software–controlled Nikon TE microscope (1.49 numerical aperture, 100× objective) equipped with a TIRF illuminator and Andor iXon charge-coupled device electron-multiplying camera. Data were analyzed manually using ImageJ (Fiji), and statistical tests were performed in GraphPad Prism 7.0c.

ATPase assays

MT-activated ATPase activity of KIF1A was analyzed in a NADH-coupled enzymatic assay (53). Initial rates of ATP hydrolysis by tail-truncated KIF1A or KIF1AP305L at 37°C were measured as follows: KIF1A or KIF1AP305L were diluted to 100 nM in SRP90 supplemented with 2 mM ATP, 0.01% Triton X-100, 1 mM DTT, and BSA (0.1 mg/ml). Coupled NADH oxidation system in the final reaction mixture was 0.1 mM NADH (Roche Diagnostics), 2 mM phosphoenolpyruvate (Sigma-Aldrich), 0.01 U pyruvate kinase (Sigma-Aldrich), and 0.03 U lactate dehydrogenase (Sigma-Aldrich). For each day of assays, taxol-stabilized MTs were assembled at 37°C for 30 min and spun down by centrifugation at 150,000g for 15 min through 25% sucrose cushion. The MT pellet was resuspended in SRP90, and 0 to 10 μM MTs were added to the reaction. The reaction mixture was preincubated for 10 s at 37°C, and the absorption at 340 nm was recorded in an Eppendorf BioSpectrometer Kinetic. Data (n = 2 to 5) were fit to the Michaelis-Menten equation by nonlinear regression to calculate KmMT and kcat values using Prism.

Optical tweezers assay

Slides, MTs, and polystyrene trapping beads were prepared as described previously (54). Briefly, carboxylate polystyrene beads (0.52 μm; Polyscience, no. 09836-15) were coated with an anti–Strep–tag II antibody (Abcam, no. ab76949) and α-casein. Glass coverslips (Zeiss, no. 474030-9000-000) were cleaned with 25% HNO3 and 2 M NaOH, washed with double-distilled water, air dried, and stored at 4°C. The flow cell was assembled with a glass slide, parafilm stripes, and a cleaned coverslip as described (54). Biotinylated MTs were attached to the coverslip surface via α-casein–biotin and streptavidin. The trapping assay was conducted as described (54) before except that the HME60K50 buffer was used for all experiments [60 mM Hepes, 50 mM KAc, 2 mM MgCl2, 1 mM EGTA, 10% glycerol, and 0.5% (w/v) Pluronic F-127]. All force measurements were performed with a LUMICKS C-Trap. The trap stiffness was set to 0.04 to 0.06 pN/nm, and the percentage of moving beads was between 10 and 45%, ensuring experiments at the single-molecule level (49). A custom-made MATLAB program was used to analyze the data. Graphs were generated using Prism (GraphPad, version 8). This is an equation line. Type the equation in the equation editor field and then put the number of the equation in the brackets at right. The equation line is a one-row table, and it allows you to both center the equation and have a right-justified reference, as found in most journals.

Structural analysis

Chimera (UCSF) was used to process the structures in fig. S1. Hydrogen bonds were found on the backbone of the helix using the FindHBond module in Chimera. Structural alignment was performed using the MatchMaker module in Chimera.

Statistical analysis

All statistical analysis was performed in GraphPad Prism version 7 or 8.


Supplementary material for this article is available at

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.


Acknowledgments: We thank all the members of the MOM lab for continual input and feedback on this project. We acknowledge the generosity and enthusiastic support of and all the families suffering with KAND. This paper is dedicated to the Rosen family and, particularly, to Susannah. We stand with you and all the KIF1A families! We also thank L. Boyle and W. Chung for helpful discussions on disease severity of the P305L mutation. Funding: This work was supported by funds from is part of the Chan Zuckerberg Initiative Rare As One Grantee Program. This work was further supported by grants from NIGMS GM124889 (to R.J.M.) and R01NS114636 (to L.R. and A.G.); the Japan Society for the Promotion of Science 20H03247, 19H04738, and 16H06536 (to S.N.); The Osamu Hayaishi Memorial Scholarship for Study Abroad (to K.C.); and a JSPS Overseas Research Fellowship (to K.C.). Author contributions: R.J.M. and A.G. designed the research and secured research funding. A.J.L., L.R., Y.A., K.C., K.O., and M.D. performed the research. D.W.N. conducted comparative analysis of published kinesin structures and created kinesin pseudomodels to aid in conceptualization. R.J.M., A.J.L., K.C., D.W.N., Y.A., and L.R. analyzed the data. R.J.M., D.W.N., and A.G wrote the paper. All authors edited the paper. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.

Stay Connected to Science Advances

Navigate This Article